Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Vanquis swings back to black, shares spark

(Sharecast News) - Shares in Vanquis Banking Group jumped on Wednesday, after the lender swung back into profit. The former Provident Financial, a specialist in mid-cost and near-prime finance, has been hit by a swathe of no-win, no-fee complaints related to its credit card division.

The costs of processing the claims, despite the "vast majority" not being upheld, saw the Bradford-based firm slump to a £34.8m loss last year.

But updating on trading on Wednesday, Vanquis said it had returned to profitability during the first quarter.

Gross customer interest-earning balances rose 1.8% in the three months to March end, to £2.3bn.

The net interest margin was 17.8%, down 1.1% annually but unchanged on the fourth quarter.

Ian McLaughlin, chief executive, said: "Vanquis' strategic delivery remains on track. The group returned to profitability and grew gross customer interest-earning balances, building on the momentum shown in the fourth quarter of 2024.

"Overall costs remained well-controlled and credit quality was robust, with our customers continuing to show financial resilience."

McLaughlin also welcome the Financial Ombudsman Service's revised fee structure, which came into effect on 1 April.

Its introduction had led to a reduction in unmerited referrals from claims management companies, he noted, with complaint costs remaining in line with expectations.

As at 1130 BST, shares in Vanquis had put on 9% at 76.34p.

Provident Financial was founded in 1880 as a doorstep lender, but faced a surge in complaints in recent years, hitting both profits and the share price.

The firm therefore opted to move away from sub-prime doorstep lending in 2023, changing its name to that of its credit card business to better reflect its mix of products.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.